Executives File New SEC Form 144 Sales

Several U.S.-listed companies saw insiders file Form 144 notices on February 27, 2026, outlining planned sales of company stock. The filings cover American Tower Corp., Vertex Pharmaceuticals (VX1d), Motorola Solutions, and Intuitive Surgical (ISRG), and specify share amounts, acquisition methods, brokers, and recent trading history where applicable.

Form 144 is used to notify the Securities and Exchange Commission of a proposed sale of restricted or control securities. The latest filings indicate that the sellers are using major brokerage firms and, in most cases, have not reported other aggregated sales over the prior three months, with Intuitive Surgical (ISRG) as a notable exception.

Vertex Pharmaceuticals (VX1d) reported a Form 144 filing for the planned sale of 40,000 common shares. The filing lists Fidelity Brokerage Services LLC, based in Smithfield, Rhode Island, as the broker handling the transaction, with an aggregate market value of $19,738,905.28. The approximate date of sale is given as February 27, 2026, and the shares are listed on NASDAQ.

According to the form, the shares derive from multiple restricted stock vesting events in February 2025. The seller acquired 9,681 shares on February 10, 2025, 6,998 shares on February 17, 2025, 8,282 shares on February 24, 2025, and 15,039 shares on February 26, 2025, each identified as compensation from the issuer. The filing reports no other securities sold by this person in the previous three months.

A Form 144 filing for Intuitive Surgical Inc. details a proposed sale of 2,345 common shares. Morgan Stanley Smith Barney LLC Executive Financial Services in New York is listed as the broker. The aggregate market value of the planned transaction is $1,171,819.95, with the sale date targeted for February 27, 2026, on NASDAQ.

The shares to be sold were acquired as restricted stock from the issuer on February 26, 2026, in a single block of 2,345 shares. Unlike other filings reported, this notice includes a detailed history of recent sales by the same seller, identified as Myriam Curet McAdams of Sunnyvale, California.

The Intuitive Surgical Form 144 lists multiple common stock sales over the prior three months. These include 421 shares sold on February 11, 2026, with gross proceeds of $208,378.16, and 105 shares sold on February 10, 2026, for $51,938.25. Additional sales occurred in January and December 2025.

The January 2026 sales comprised 126 shares on January 29 for $65,522.52 and 230 shares on January 27 for $122,500.30. Earlier, the filer sold 104 shares on December 10, 2025, for $58,229.60 and 125 shares on December 1, 2025, for $71,123.75. These transactions are disclosed to satisfy aggregation requirements under Rule 144.

American Tower Corp. filed a Form 144 indicating a proposed sale of 2,310 common shares. The notice lists Morgan Stanley Smith Barney LLC Executive Financial Services in New York as broker, with an aggregate market value of $427,373.10. The intended sale date is February 27, 2026, and the shares trade on the NYSE.

The securities to be sold were acquired as restricted stock units from the issuer on March 12, 2022, in an amount of 2,310 units. The form specifies that these securities were not received as a gift and reports no sales by this person in the prior three months, suggesting this filing covers a new disposition of those units.

Motorola Solutions Inc. (NYSE: MSI) reported a Form 144 for the sale of 407 common shares, with an aggregate market value of $194,908.23. The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as broker and lists an approximate sale date of February 27, 2026, on the NYSE.

The underlying equity awards consist of 359 performance shares acquired on March 10, 2025, and 48 restricted stock shares acquired on September 3, 2025, both from the issuer. The form indicates no securities sold by this individual in the prior three months, and describes the nature of payment as not applicable for these awards.